HIGHLIGHTS
- who: Meiling Sun from the Department of Pulmonary and Critical Care Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, No, Wenhua Xilu, Jinan, Shandong, China have published the research work: Real-world data analysis of immune checkpoint inhibitors in stage III-IV adenocarcinoma and squamous cell carcinoma, in the Journal: (JOURNAL) of March/31,/2021
- what: Background: This study was designed to investigate the clinical application efficacy and safety of immune checkpoint inhibitors (ICIs) in the treatment of lung in the real world. The results of this study showed that the use of corticosteroids . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.